The 3D printing healthcare market classifications are based on category (products, services and materials), process, applications, end-users and geography. In the category segment, materials are further classified into metal, polymer, ceramic and others (donor cells and pharmaceutical material) where, polymer segment is holding major share. Further, the 3D printing healthcare by process is divided into photopolymerization, deposition, fusion, and jetting.
3D printing technology is expanding rapidly in medical/healthcare sector with its wide number of applications in medical, implants, drug manufacturing and so on. As patients are benefited by trending 3D printing technology in terms of customization, accuracy and durability, traditional methods are being replaced.
Today, much research and development work is ongoing in 3D printing medical sector in order to re-shape the healthcare market by bringing advancement in 3D printing technology by developing innovative products day-by-day. At present, 3D printing technology is significantly poised to grow in medicine sector where, the drug toxicity is tested on human tissue instead of animals. 3D printing is being used in pharmaceutical industry where personalized medicines with appropriate dosage size, color and delivery mode are made to improve patient care.
For instance, Spritam, an anti-epileptic drug developed by Aprecia Pharmaceuticals using 3D printing technology, has undergone trials and is set to be launched in early 2016. Possibility of the transplantation of 3D printed organs such as a heart or liver into the human body has emerged in the past few years; and embryonic stem cells are being generated by 3D printing technology.
The application sector is classified into implant (dental, orthopedic, hearing aid and others), tissue engineering, surgical guides, surgical instruments, pharmaceutical applications, whereas end-users is segmented into hospitals, biotech and pharmaceutical companies, academic institutions and others. Geography is divided into North America, Europe, Asia-Pacific and Rest of the world.